Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.cabalettabio.com/news-media/press-releases/detail/112/cabaletta-bio-reports-positive-initial-clinical-data-from
https://www.globenewswire.com/news-release/2024/06/14/2898772/0/en/Cabaletta-Bio-Reports-Positive-Initial-Clinical-Data-from-Phase-1-2-RESET-Myositis-and-RESET-SLE-Trials-of-CABA-201.html
https://www.globenewswire.com/news-release/2024/05/29/2889809/0/en/Cabaletta-Bio-to-Participate-in-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/15/2882253/0/en/Cabaletta-Bio-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/13/2880362/0/en/Cabaletta-Bio-to-Participate-in-the-H-C-Wainwright-2nd-Annual-BioConnect-Investor-Conference-at-NASDAQ.html
https://endpts.com/additional-drugmakers-flag-risks-of-working-with-wuxi-amid-heightened-us-scrutiny/
https://www.globenewswire.com/news-release/2024/03/21/2850085/0/en/Cabaletta-Bio-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/20/2849225/0/en/Cabaletta-Bio-Announces-FDA-Granted-Orphan-Drug-Designation-to-CABA-201-for-Treatment-of-Systemic-Sclerosis.html
https://www.globenewswire.com//news-release/2024/02/27/2835938/0/en/Cabaletta-Bio-to-Participate-in-Upcoming-Investor-Conferences-in-March.html